Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report

INTRODUCTION: Treatment of hepatitis C infection has evolved dramatically since 2011. Previous conventional therapy with interferon and ribavirin used to have a low sustained virological response rate of less than 40%. In the new direct-acting antiviral therapy era, a sustained virological response...

Descripción completa

Detalles Bibliográficos
Autores principales: Qatomah, Abdulrahman, Bukhari, Majidah, Cupler, Edward, Alardati, Hosam, Mawardi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686586/
https://www.ncbi.nlm.nih.gov/pubmed/34924025
http://dx.doi.org/10.1186/s13256-021-03138-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686586/
https://www.ncbi.nlm.nih.gov/pubmed/34924025
http://dx.doi.org/10.1186/s13256-021-03138-0

Ejemplares similares